Atorvastatin: Dr Reddy's to contest Pfizer's suit

Drug maker Dr Reddy's Laboratories will contest the patent infringement case filed against it by the global pharmaceutical giant Pfizer over its cholesterol lowering drug atorvastatin, said a......

Weak rupee, China woes drag Sensex below 25,000; Nifty breaches 7,600

Bank shares were the top losers on concerns that NIMs would take a hit on recent cut in base rate. Benchmark shares indices ended lower for the sixth straight session amid sell-off in late trades......

Ranbaxy recalls some batches of generic Lipitor in latest quality blow

Indian drugmaker Ranbaxy Laboratories Ltd, reeling under a flurry of regulatory rebukes due to manufacturing quality concerns, has recalled more than 64,000 bottles of the generic version of a......

Ranbaxy's Lipitor generic may miss Dec deadline for return to US market

Ranbaxy's generic version of Lipitor, which faced recall from the US market last month, could remain missing at the beginning of 2013, if the company fails to resume supplies of the drug by the end......